Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial

The aim of this study was to determine if orlistat, an inhibitor of fat absorption, combined with caloric restriction in overweight subjects with nonalcoholic steatohepatitis results in weight loss and improved liver histology. Fifty overweight subjects (body mass index = ≥27) with biopsy proven non...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hepatology (Baltimore, Md.) Md.), 2009-01, Vol.49 (1), p.80-86
Hauptverfasser:	Harrison, Stephen A., Fecht, Will, Brunt, Elizabeth M., Neuschwander‐Tetri, Brent A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anti-Obesity Agents - therapeutic use Biological and medical sciences Diet, Reducing Fatty Liver - drug therapy Fatty Liver - physiopathology Female Gastroenterology. Liver. Pancreas. Abdomen Humans Lactones - therapeutic use Liver. Biliary tract. Portal circulation. Exocrine pancreas Male Medical sciences Metabolic diseases Middle Aged Obesity Obesity - drug therapy Obesity - physiopathology Weight Loss - drug effects Weight Loss - physiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!